Teicoplanin reduces in-vitro reactivity and murine lethality of Salmonella minnesota R595 lipopolysaccharide

J Antimicrob Chemother. 1992 Apr;29(4):443-6. doi: 10.1093/jac/29.4.443.

Abstract

Three different tests were performed to investigate the effect of teicoplanin on lipopolysaccharide (LPS). After incubation for 3 h with teicoplanin, LPS from Salmonella minnesota R595 showed reduced reactivity in the metachromatic dimethyl-methylene blue assay and the limulus amoebocyte lysate test. In addition, galactosamine-sensitized mice had an increased survival rate, from 29% to 72%, when teicoplanin was pre-incubated for 3 h with the LPS to be injected intraperitoneally. The results suggest that teicoplanin may have a neutralizing effect on LPS.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology*
  • Galactosamine / pharmacology
  • Glycopeptides / pharmacology
  • Limulus Test
  • Lipopolysaccharides / toxicity*
  • Male
  • Methylene Blue / analogs & derivatives
  • Mice
  • Mice, Inbred C57BL
  • Polymyxin B / pharmacology
  • Salmonella / drug effects*
  • Teicoplanin

Substances

  • Anti-Bacterial Agents
  • Glycopeptides
  • Lipopolysaccharides
  • Teicoplanin
  • Galactosamine
  • Polymyxin B
  • Methylene Blue
  • 1,9-dimethylmethylene blue